This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of TherapeuticsMD Inc. (TXMD) soared 20.88% to $2.20 Friday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index rising 0.31% to 25,888.84 and the Dow Jones Industrial Average rising 0.70% to 51,202.26.
The stock's rise snapped a two-day losing streak.
TherapeuticsMD Inc. closed 25.42% short of its 52-week high of $2.95, which the company achieved on January 27th.
The stock outperformed some of its competitors Friday, as AbbVie Inc. (ABBV) rose 1.32% to $227.73.
Trading volume (258,976) eclipsed its 50-day average volume of 32,180.
Data source: Dow Jones Market Data, FactSet. Data compiled June 12, 2026.
This content was created by MarketWatch, which is operated by Dow Jones &amp; Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
06-12-26 1731ET

TXMD

TherapeuticsMD Inc. (TXMD) shares surged 20.88% to $2.20, outperforming competitors like AbbVie and snapping a two-day losing streak. Trading volume significantly exceeded the 50-day average. The rise occurred during a favorable market session where the NASDAQ and Dow Jones also gained.

TherapeuticsMD Inc. Stock Outperforms Competitors On Strong Trading Day